Chugai Pharmaceutical Co., Ltd. (CHGCY)
OTCMKTS: CHGCY · Delayed Price · USD
15.38
-0.21 (-1.35%)
Apr 26, 2024, 3:59 PM EDT - Market closed
Chugai Pharmaceutical Co. Income Statement
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2003 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,111,367 | 1,259,946 | 999,759 | 786,946 | 686,184 | 579,787 | 534,199 | 491,780 | 498,839 | 461,109 | Upgrade
|
Revenue Growth (YoY) | -11.79% | 26.02% | 27.04% | 14.68% | 18.35% | 8.53% | 8.63% | -1.42% | 8.18% | 8.84% | Upgrade
|
Cost of Revenue | 418,358 | 476,251 | 338,147 | 273,465 | 266,071 | 262,847 | 254,171 | 247,944 | 240,238 | 218,076 | Upgrade
|
Gross Profit | 693,009 | 783,695 | 661,612 | 513,481 | 420,113 | 316,940 | 280,028 | 243,836 | 258,601 | 243,033 | Upgrade
|
Selling, General & Admin | 112,580 | 100,760 | 102,416 | 94,401 | 101,574 | 93,416 | 88,147 | 81,941 | 88,018 | 86,374 | Upgrade
|
Research & Development | 164,764 | 149,626 | 137,299 | 117,850 | 107,942 | 99,202 | 92,947 | 85,011 | 83,799 | 80,800 | Upgrade
|
Other Operating Expenses | 0 | -2,134 | -2,540 | -1,504 | -3,124 | -3,212 | -1,706 | -3,460 | 0 | 1 | Upgrade
|
Operating Expenses | 277,344 | 250,386 | 239,715 | 212,251 | 209,516 | 192,618 | 181,094 | 166,952 | 171,817 | 167,174 | Upgrade
|
Operating Income | 415,665 | 533,309 | 421,897 | 301,230 | 210,597 | 124,323 | 98,934 | 76,884 | 86,784 | 75,859 | Upgrade
|
Interest Income | 1,482 | 182 | 166 | 121 | 109 | 0 | 0 | 1,111 | 559 | 0 | Upgrade
|
Interest Expense | 27 | 61 | 48 | 62 | 125 | 111 | 110 | 86 | 67 | 11 | Upgrade
|
Other Expense / Income | -26,701 | 2,264 | 2,630 | 3,101 | 2,688 | 3,354 | 2,621 | 4,241 | 1,228 | 781 | Upgrade
|
Pretax Income | 443,821 | 531,166 | 419,385 | 298,188 | 207,893 | 121,449 | 97,031 | 74,448 | 87,276 | 76,164 | Upgrade
|
Income Tax | 118,349 | 156,737 | 116,390 | 83,455 | 50,333 | 28,370 | 23,490 | 20,076 | 24,923 | 24,087 | Upgrade
|
Net Income | 325,472 | 374,429 | 302,995 | 214,733 | 157,560 | 92,488 | 72,713 | 53,592 | 61,125 | 50,980 | Upgrade
|
Net Income Growth | -13.08% | 23.58% | 41.10% | 36.29% | 70.36% | 27.20% | 35.68% | -12.32% | 19.90% | 0.17% | Upgrade
|
Shares Outstanding (Basic) | 1,645 | 1,645 | 1,644 | 1,643 | 1,642 | 3,289 | 3,279 | 3,277 | 3,275 | 3,270 | Upgrade
|
Shares Outstanding (Diluted) | 1,645 | 1,645 | 1,645 | 1,645 | 1,645 | 3,289 | 3,285 | 3,282 | 3,281 | 3,276 | Upgrade
|
Shares Change | 0.01% | 0.01% | 0.01% | 0.03% | -50.00% | 0.14% | 0.08% | 0.04% | 0.16% | 0.14% | Upgrade
|
EPS (Basic) | 197.83 | 227.64 | 184.29 | 130.66 | 95.95 | 28.12 | 22.17 | 16.35 | 18.67 | 15.59 | Upgrade
|
EPS (Diluted) | 197.80 | 227.57 | 184.17 | 130.53 | 95.81 | 28.12 | 22.14 | 16.33 | 18.63 | 15.56 | Upgrade
|
EPS Growth | -13.08% | 23.57% | 41.09% | 36.24% | 240.72% | 27.01% | 35.58% | -12.35% | 19.73% | 0% | Upgrade
|
Free Cash Flow | 337,068 | 172,873 | 206,760 | 143,624 | 145,464 | 41,403 | 63,097 | 2,365 | 37,655 | 17,867 | Upgrade
|
Free Cash Flow Per Share | 204.84 | 105.07 | 125.67 | 87.31 | 88.45 | 12.59 | 19.21 | 0.72 | 11.48 | 5.45 | Upgrade
|
Gross Margin | 62.36% | 62.20% | 66.18% | 65.25% | 61.22% | 54.66% | 52.42% | 49.58% | 51.84% | 52.71% | Upgrade
|
Operating Margin | 37.40% | 42.33% | 42.20% | 38.28% | 30.69% | 21.44% | 18.52% | 15.63% | 17.40% | 16.45% | Upgrade
|
Profit Margin | 29.29% | 29.72% | 30.31% | 27.29% | 22.96% | 15.95% | 13.61% | 10.90% | 12.25% | 11.06% | Upgrade
|
Free Cash Flow Margin | 30.33% | 13.72% | 20.68% | 18.25% | 21.20% | 7.14% | 11.81% | 0.48% | 7.55% | 3.87% | Upgrade
|
Effective Tax Rate | 26.67% | 29.51% | 27.75% | 27.99% | 24.21% | 23.36% | 24.21% | 26.97% | 28.56% | 31.63% | Upgrade
|
EBITDA | 447,405 | 531,227 | 419,433 | 298,250 | 208,018 | 121,560 | 97,141 | 74,534 | 87,343 | 76,175 | Upgrade
|
EBITDA Margin | 40.26% | 42.16% | 41.95% | 37.90% | 30.32% | 20.97% | 18.18% | 15.16% | 17.51% | 16.52% | Upgrade
|
Depreciation & Amortization | 31,740 | 31,434 | 30,868 | 30,476 | 26,401 | 0 | 16,334 | 16,369 | 15,567 | 14,880 | Upgrade
|
EBIT | 415,665 | 499,793 | 388,565 | 267,774 | 181,617 | - | 80,807 | 58,165 | 71,776 | 61,295 | Upgrade
|
EBIT Margin | 37.40% | 39.67% | 38.87% | 34.03% | 26.47% | - | 15.13% | 11.83% | 14.39% | 13.29% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.